Regulatory mechanisms of replication growth limits in cellular senescence

Journal of the Formosan Medical Association

Volumn 96, Issue 10, 1997, Pages 784-791

  Chang, Zee Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Cell cycle; Cyclin dependent kinase inhibitor; Senescence; Telomere

Indexed keywords

CYCLIN DEPENDENT KINASE;

APOPTOSIS; CELL AGING; CELL CYCLE; ETIOLOGY; FIBROBLAST; HUMAN; HUMAN CELL; LIFESPAN; REGULATORY MECHANISM; REVIEW; SENESCENCE; TELOMERE;

ANIMALS; APOPTOSIS; CELL AGING; CELL DIVISION; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; G1 PHASE; HUMANS;

EID: 0030827525     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (109)

1. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
2. Hayflick L: The limited in vitro lifetime of human diploid cell strains. Exp Cell Res 1965;37:614-36.
3. Martin GM, Sprague CA, Epstein CJ: Replicative lifespan of cultivated human cells: effects of donor's age, tissue and genotype. Lab Invest 1970;23:86-92.
4. Goldstein S, Murano H, Benes EJ, et al: Studies on the molecular genetics basis of replicative senescence in Werner syndrome and normal fibroblasts. Exp Gerontol 1989;24:461-8.
5. Rohme D: Evidence for a relationship between longevity of mammalian species and lifespans of normal fibroblasts in vitro and erythrocytes in vivo. Proc Natl Acad Sci USA 1981;78:5009-13.
6. Smith JR, Pereira-Smith OM: Replicative senscence: implication for in vivo aging and tumor suppression. Science 1996;273:63-7.
7. Campisi J: Replicative senescence: an old lives' tale. Cell 1996;84:497-500.
8. Stein GH, Dulic V: Origins of G1 arrest in senescent human fibroblasts. BioEssays 1995;17:537-43.
9. Cristofalo VJ, Sharf BB: Cellular senescence and DNA synthesis: thymidine incorporation as a measure of population age in human diploid cells. Exp Cell Res 1973;76:419-27.
10. Goldstein S: Replicative senescence: the human fibroblast comes of age. Science 1990;249:1129-33.
11. Harley CB, Goldstein S: Retesting the commitment theory of cellular aging. Science 1980;207:191-3.
12. Cristofalo VJ, Phillips PD, Sorger T, et al: J Gerontol 1989;44:55.
13. Sherwood SW, Rush D, Ellsworth JL, et al: Proc Natl Acad Sci USA 1988;85:9086-9.
14. Ferber A, Chang C, Sell C, et al: Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene. J Biol Chem 1993;268:17883-8.
15. Gerhard GS, Phillips PD, Cristofalo VJ: EGF and PDGF-stimulated phosphorylation in young and senescent WI-38 cells. Exp Cell Res 1991;193:87-92.
16. Paulsson Y, Bywater M, Pfeifer-Ohisson S, et al: Growth factors induce early pre-replicative changes in senescent human fibroblasts. EMBO J 1986;5:2157-61.
17. Rittling SR, Brooks KM, Cristofalo VJ, et al: Expression of cell cycle-dependent genes in voting and senescent WI-38 fibroblasts. Proc Natl Acad Sci USA 1986;83:3316-20.
18. Sheshadri T, Campisi J: Repression of c-fos transcription and an altered genetic program in senescent human fibroblasts. Science 1990;247:205-9.
19. Pignolo RJ, Cristofalo VJ, Philips PD: Altered expression of AP-1 binding activity but not c-jun or jun-B mRNA expression in senescent WI-38 cells. J Cell Biol 1990;111:498 [Abstract].
20. Dulic V, Drullinger LF, Lees E, et al: Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-cdk2 and cyclin D1-cdk2 complexes. Proc Natl Acad Sci USA 1993;90:11034-8.
21. Norwood TH, Pendergrass WR, Sprague CA, et al: Dominance of the senescent phenotype in heterokaryons between replicative and postreplicative human fibroblast cell. Proc Natl Acad Sci USA 1974;71:2231-4.
22. Rabinowitch PS, Norwood TH: Comparative heterokaryon study of cellular senescence and the serum-deprived state. Exp Cell Res 1980;130:101-9.
23. Yanishevsky RM, Stein GH: Ongoing DNA synthesis continues in young human diploid cells (HDC) fused to senescent HDC, but entry into S phase is inhibited. Exp Cell Res 1980;126:469-72.
24. Lumpkin CK, McClung JK, Pereira-Smith OM, et al: Existence of high abundance and antiproliferative mRNA's in senescent human diploid fibroblasts. Science 1986;232:393-5.
25. Noda A, Ning Y, Venable SF, et al: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994;211:90-8.
26. El-Diery WS, Harper JW, O'Connor PM, et al: WAF1, a potential mediator of p53 tumour suppression. Cell 1993;75:817-25.
27. Harper JW, Adami GR, Wei N, et al: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cdks, Cell 1993;75:805-16.
28. Xiong Y, Hannon GJ, Zhang H, et al: p21 is a universal inhibitor of cyclin kinases. Nature 1993;366:701-4.
29. Waga S, Hannon GJ, Beach D, et al: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 1994;369:574-8.
30. Weintraub SJ, Prater CA, Dean DC: Retinoblastoma protein switches the E2F site from positive to negative element. Nature 1992;358:259-61.
31. Hiebert SW: Regions of the retinoblastoma gene product required for its interaction with the E2F transcription factor are necessary for E2 promoter repression and pRb-mediated growth suppression. Mol Cell Biol 1993;13:3384-91.
32. Dimri GP, Nakanishi M, Desprez PY, et al: Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein. Mol Cell Biol 1996;16:2987-97.
33. Goodrich DW, Wang NP, Qian YW, et al: The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 1991;67:293-302.
34. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 1995;81:323-30.
35. Lucibello FC, Sewing A, Brusselbach S, et al: Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993;105:123-33.
36. Stein GH, Beeson M, Gordon L: Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. Science 1990;249:666-9.
37. Chellappan SP, Hiebert S, Mudrvj M, et al: The E2F transcription factor is a cellular target for the Rb protein. Cell 1991;65:1053-61.
38. Hiebert SW, Chellapan SP, Horowitz JM, et al: The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev 1991;6:177-85.
39. Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 1992;258:424-9.
40. Stein GH, Drullinger LF, Robetorye OM, et al: Senescent cells fail to express cdc2, cycA, and cycB in response to mitogen stimulation. Proc Natl Acad Sci USA 1991; 88:11012-6.
41. Pang JH, Chen KY: Global change of gene expression at late G1/S boundary may occur in human IMR-90 diploid fibroblasts during senescence. J Cell Physiol 1994;160:531-8.
42. Afshari CA, Nichols MA, Xiong Y: A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts. Cell Growth Diff 1996;7:979-88.
43. Dimri GP, Hara E, Campisi J: Regulation of two E2F-related genes in presenescent and senescent human fibroblasts. J Biol Chem 1994;269:16180-6.
44. Chang ZF, Chen KY: Regulation of ornithine decarboxylase and other cell cycle-dependent genes during senescence of IMR-90 human diploid fibroblasts. J Biol Chem 1988;263:11431-5.
45. DeGregori J, Kowalik T, Nevins JR: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis and G1/S regulatory genes. Mol Cell Biol 1995;15:4215-24.
46. Bond JA, Blaydes JP, Rowson J, et al: Mutant p53 rescues human diploid cells from senescence without inhibiting induction of sdi/Waf1. Cancer Res 1995;55:2404-9.
47. Alcorta DA, Xiong Y, Phelps D, et al: Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci USA 1996;93:13742-7.
48. Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-7.
49. Kamb A, Gruis NA, Weaver-Feldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 1994;264:436-40.
50. Lukas J, Parry D, Aagaard L, et al: Retinoblastoma-protein-dependent cell cycle inhibition by the tumour suppressor p16. Nature 1995;375:503-6.
51. CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol 1996;16:859-67.
52. El-Deiry WS, Harper JW, O'Conner PM, et al: WAF1/ CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
53. Michieli P, Chedid M, Lin D, et al: Induction of WAF1/ CIP1 by a p53-independent pathway. Cancer Res 1994;54:3391-5.
54. Steinman RA, Hoffman B, Iro A, et al: Induction of p21 (WAF1/CIP1) during differentiation. Oncogene 1994;9:3389-96.
55. Sheikh MS, Li XS, Chen JC, et al: Mechanisms of regulation of WAF1/CIP1 gene expression in human breast carcinoma: role of p53-dependent and independent signal transduction pathways. Oncogene 1994;9:3407-15.
56. Jiang H, Lin J, Su Z, et al: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF1/CIP1 expression in the absence of p53. Oncogene 1994;9:3397-406.
57. Elbendary A, Berchuck A, Davis P, et al: Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Diff 1994;5:1301-7.
58. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996;10:142-53.
59. Zhang W, Grasso L, McClain CD, et al: p53-independent induction of WAF1/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/ macrophage differentiation. Cancer Res 1995;55:668-74.
60. Zeng YK, El-Deiry WS: Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 1996;12:1557-64.
61. Macleod KF, Sherry N, Hannon G, et al: p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 1995;9:935-44.
62. Datto MB, Li Y, Panus J, et al: Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 1995;92:5545-9.
63. Biggs JR, Kudlow JE, Kraft AS: The role of the transcription factor Sp1 in regulating the expression of the WAF1/ CIP1 gene in U937 leukemia cells. J Biol Chem 1996; 271:901-6.
64. WAF1/CIP1 mediated by STAT1. Science 1996;272:719-22.
65. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 1996;271:31723-8.
66. Riabowol KT, Vosatka RJ, Ziff EB, et al: Microinjection of c-fos-specific antibodies blocks DNA synthesis in fibroblast cells. Mol Cell Biol 1988;8:1670-6.
67. Riabowol KT, Schiff J, Gilman MZ: Transcription factor Ap-1 activity is required for initiation of DNA synthesis and is lost during cellular aging. Proc Natl Acad Sci USA 1992;83:3316-28.
68. Rose DW, McCabe G, Feramisco JR, et al: Expression of c-fos and AP-1 activity in senescent human fibroblasts is not sufficient for DNA synthesis. J Cell Biol 1992;119:1405-11.
69. Atadja PW, Stringer KF, Riabowol KT: Loss of serum response element-binding activity and hyperphosphorylation of serum response factor during cellular aging. Mol Cell Biol 1994;14:4991-9.
70. Venable ME, Blobe GC, Obeid LM: Identification of a defect in the phospholipase D/diacylglycerol pathway in cellular senescence. J Biol Chem 1994;269:26040-4.
71. Chang ZF, Huang DY: Decline of protein kinase C activation in response to growth stimulation during senescence of IMR-90 human diploid fibroblasts. Biochem Biophys Res Commun 1994;200:16-27.
72. De Tata V, Ptasznik A, Cristofalo V: Effect of the tumor promoter phorbol 12-myristate 13-acetate (PMA) on proliferation of young and senescent WI-38 human diploid fibroblasts. Exp Cell Res 1993;205:261-9.
73. Hara E, Yamaguchi T, Nojima H, et al: Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. J Biol Chem 1994;269:2139-45.
74. Wang E: Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res 1995;55:2284-92.
75. Wang E, Lee MJ, Pandey S: Control of fibroblasts senescence and activation of programmed cell death. J Cell Biochem 1994;54:432-9.
76. WAF1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 1996;16:1335-41.
77. Wang J, Walsh K: Resistance to apoptosis conferred by cdk inhibitors during myotube differentiation. Science 1996;273:359-61.
78. Dimri GP, Lee X, Basile G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363-7.
79. Wick M, Burger C, Brusselbach S, et al: A novel member of human inhibitor of metalloproteinases (TIMP) gene family is regulated during G1 progression, mitogenic stimulation, differentiation, and senescence. J Biol Chem 1994;269:18953-60.
80. Wright WE, Pereira-Smith OM, Shay JW: Reversible cellular senescence: implication for immortalization of normal human diploid fibroblasts. Mol Cell Biol 1989;9:3088-92.
81. Hara E, Tsurui H, Shinozaki A, et al. Cooperative effect of antisense-Rb and antisense-p53 oligomers on the extension of life span in human diploid fibroblasts, TIG-1. Biochem Biophys Res Comm 1991;179:528-34.
82. Yu C, Oshima J, Fu YH, et al: Positional cloning of the Werner's syndrome gene. Science 1996;272:258-62.
83. Harley CB, Futcher AB, Greider C: Telomeres shorten during ageing of human fibroblasts. Nature 1990;345: 458-60.
84. Harley CB, Varziri H, Counter CM, et al: The telomere hypothesis of cellular aging. Exp Gerontol 1992;27:375-82.
85. Kim NW: Specific association of human telomere activity with immortal cells and cancer. Science 1994;266:2011-5.
86. Broccoli D, Young JW, de Lange T: Telomerase activity in normal and haematopoietic cells. Proc Natl Acad Sci USA 1995;92:9082-6.
87. Chen Q, Ames BN: Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblasts F65 cells. Proc Natl Acad Sci USA 1994;91:4130-4.
88. Ames BN, Shigenaga MK, Hagen TM: Oxidant, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993;90:7915-22.
89. Johnson TE: Increased life-span of age-1 mutants in Caenorhabditis elegans and lower Gompertz rate of aging. Science 1990;249:908-12.
90. Orr W, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster. Science 1994;263:1128-30.
91. Phillips JP, Campbell SD, Michaud D, et al: Null mutations of copper/zinc superoxide dismutase in Drosophila confers hypersensitivity to paraquat and reduced longevity. Proc Natl Acad Sci USA 1989;86:2761-5.
92. Wong A, Boutis P, Hekimi S: Mutations in the clk-1 gene of Caenorhabditis elegans affect developmental and behavioral time. Genetics 1995;139:1247-59.
93. Lakowski B, Hekimi S: Determination of life-span in Caenorhabditis elegans by four clock genes. Science 1996;272:1010-3.
94. Ewbank JJ, Barnes TM, Lakowski B, et al: Structural and functional conservation of the Caenorhabditis elegans timing gene clk-1. Science 1997;275:980-3.
95. Stein GH, Yanishevsky RM: Entry into S phase is inhibited in two immortal cell lines fused to senescent human diploid cells. Exp Cell Res 1979;120:155-65.
96. Pereira-Smith OM, Smith JR: Evidence for the recessive nature of cellular immortality. Science 1983;221:964-6.
97. Pereira-Smith OM, Smith JR: Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc Natl Acad Sci USA 1988; 85:6042-6.
98. Sugawara O, Oshimura M, Koi M, et al: Induction of cellular senescence in immortalized cell by human chromosome 1. Science 1990;247:707-10.
99. Hensler PJ, Annab LA, Barrett JC, et al: A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 1994;14: 2291-7.
100. Ning Y, Weber JL, Killary AM, et al: Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 1991;88:5635-9.
101. Ogata T, Ayusawa D, Namba M, et al: Chromosome 7 suppresses indefinite division of nontumorigenic immortalized human fibroblast cell line KMST-6 and SUSM-1. Mol Cell Biol 1993;13:6036-43.
102. Sandhu AK, Hubbard K, Kaur GP, et al: Senescence of immortal human fibroblasts by the introduction of normal human chromosome 6. Proc Natl Acad Sci USA 1994;91:5498-502.
103. Klein CB, Conway K, Wang XW, et al: Senescence of 'nickel-transformed' cells by an X chromosome: possible epigenetic control. Science 1991;251:796-9.
104. Loughran O, Edington KG, Berry IJ, et al: Loss of heterozygosity of chromosome 9p21 is associated with the immortal phenotype of neoplastic human head and neck keratinocytes. Cancer Res 1994;54:5054-49.
105. Milo GE, DiPaolo JA: Neoplastic transformation of human diploid cells in vitro after chemical carcinogen treatment. Nature 1978;275:130-2.
106. Kakunaga T: Neoplastic transformation of human diploid fibroblast cells by chemical carcinogens Proc Natl Acad Sci USA 1978;75:1334-8.
107. Borek C: X-ray induced in vitro neoplastic transformation of human diploid cells. Nature 1980;183: 776-8.
108. O'Brien W, Stenman G, Sager R: Suppression of tumor growth by senescence in virally transformed human fibroblasts. Proc Natl Acad Sci USA 1986;83: 8659-63.
109. Preston GA, Lang JE, Maronpot RR, et al: Regulation of apoptosis by low serum in cells of different stages of neoplastic progression: enhanced susceptibility after loss of a senescence gene and decreased susceptibility after loss of a tumor suppressor gene. Cancer Res 1994; 54:4214-23.